Publicaciones en las que colabora con María Dolores Pastor Herrera (15)

2023

  1. Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2021

  1. Identification of predictive biomarkers of response to hsp90 inhibitors in lung adenocarcinoma

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-18

2016

  1. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF)

    Journal of Thoracic Oncology, Vol. 11, Núm. 12, pp. 2183-2192

2015

  1. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 3

  2. Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 6151-6159

2014

  1. MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

    BMC Cancer, Vol. 14, Núm. 1

  2. MicroRNA clusters: Dysregulation in lung adenocarcinoma and COPD

    European Respiratory Journal, Vol. 43, Núm. 6, pp. 1740-1749

  3. MicroRNA-dependent regulation of transcription in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 3

  4. VeriStrat: A prognostic and/or predictive biomarker for advanced lung cancer patients?

    Expert Review of Respiratory Medicine, Vol. 8, Núm. 1, pp. 1-4

2013

  1. Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage

    International Journal of Molecular Sciences, Vol. 14, Núm. 2, pp. 3440-3455

  2. Identification of proteomic signatures associated with lung cancer and COPD

    Journal of Proteomics, Vol. 89, pp. 227-237

  3. Proteomic biomarkers in lung cancer

    Clinical and Translational Oncology, Vol. 15, Núm. 9, pp. 671-682

2012

  1. Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies

    Disease Markers, Vol. 32, Núm. 4, pp. 221-230

  2. PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: Incidence and implications in clinical outcome

    BMC Cancer, Vol. 12

2011

  1. Down-regulation of spinophilin in lung tumours contributes to tumourigenesis

    Journal of Pathology, Vol. 225, Núm. 1, pp. 73-82